Rafael Holdings, Inc. (RFL)
NYSE: RFL · Real-Time Price · USD
1.470
+0.040 (2.80%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Rafael Holdings Earnings Call Transcripts
Fiscal Year 2026
-
Top-line phase III results for Trappsol Cyclo in Niemann-Pick Disease Type C showed a favorable trend in slowing disease progression, with statistical significance in a key subgroup and strong survival benefit in infantile-onset patients. Safety was consistent with prior studies.